The development and progress of nanomedicine for esophageal cancer diagnosis and treatment

X Li, L Chen, S Luan, J Zhou, X Xiao, Y Yang… - Seminars in cancer …, 2022 - Elsevier
Esophageal cancer (EC) is a common gastrointestinal malignancy with poor prognosis and
high mortality. Although combined therapeutic strategies have been developed, the 5-year …

Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform

G Ren, ZC Wang, Y Tian, J Li, Y Ma, L Zhou… - Biomedicine & …, 2022 - Elsevier
As the sixth leading cause of cancer death, esophageal cancer is threatening the life of
people worldwide. Traditional treatments, such as surgery, chemotherapy, radiotherapy, are …

[HTML][HTML] Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced …

S Zhou, Y Yang, Q Zhang, C Zhu, P Cai… - Annals of Translational …, 2023 - ncbi.nlm.nih.gov
Background Esophageal cancer is one of the most common malignant tumors in China.
Patients with advanced esophageal cancer often cannot be treated by surgery; in these …

Radiotherapy Target Volumes in Esophageal Cancer: The Twisting Kaleidoscope

G Sarma, J Nath, B Sarma - Journal of Radiation and Cancer …, 2023 - journals.lww.com
Incidence of carcinoma esophagus accounts for approximately 6% of all gastrointestinal
malignancies. According to GLOBOCAN 2020 data, 604,100 cases of carcinoma esophagus …

[引用][C] Radiation induced lymphopenia in head and neck cancer: The importance of rigorous statistical analysis, radiation field size, and treatment modality

R Chow, CB Simone - Radiotherapy and Oncology, 2022 - thegreenjournal.com
We read with interest the systematic review and meta-analysis by Dai et al [1], which
reported on radiation induced lymphopenia and its negative impact on overall survival and …